PatentsGlobal
AimwellBio Releases Detailed Investor Briefing on $10 Million Trustr IP Portfolio Acquisition
AimwellBio has published an in-depth investor briefing detailing its recent acquisition of the Trustr intellectual property portfolio, valued at $10 million. The briefing outlines the technology’s institutional origins, patent filings, and applications in healthcare, underscoring AimwellBio’s commitment to transparenc…
Thursday, August 13, 2026